Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. HMI Medical targets more overseas patients with robotic surgery push 2. Australian gov’t allocates $970,000 to sustain cohealth GP services 3. SGH launches neuroscience ICU to support critical cases 4. Precious Medical Group launches $121.m cancer centre and hospital in Johor 5. NHG Health unveils Serangoon Polyclinic in SingaporeResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
